Kabiramide C

Star0

DB03616ExperimentalSmall molecule

Kabiramide C: Overview.

Formula / weight: C₄₈H₇₅N₅O₁₄ · 946.1342 g/mol (avg)

Resolves to

Compound

PubChem5288658

Structure

InChIKeyXYKNXOJYKRVXBX-ZAUPHERQSA-NSMILES

[H]\C(=C(\[H])[C@@]([H])(C)[C@@]([H])(OC)[C@@]([H])(C)C(=O)CC[C@]([H])(C)[C@]([H])(C[C@]1([H])OC(=O)C[C@]([H])(C[C@]([H])(C)C[C@]([H])(O)[C@]([H])(C)[C@@]([H])(OC)C2=COC(=N2)C2=COC(=N2)C2=COC(=N2)\C([H])=C([H])\C[C@]([H])(OC)[C@@]1([H])C)O[C@]([H])(N)O)OC)N(C)CO

Targets

P68133ACTA1

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Kabiramide C, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account